DNA vaccine for use in pancreatic cancer patients

DNA vaccine for use in pancreatic cancer patients

  • CN 104,519,908 A
  • Filed: 06/26/2013
  • Published: 04/15/2015
  • Est. Priority Date: 07/05/2012
  • Status: Active Application
First Claim
Patent Images

1. the salmonella typhi mutant strain of the attenuation of the recombinant DNA molecules of expression assembly that contain at least one copy, that comprise coding vegf receptor protein, vegf receptor protein is selected from by mankind VEGFR-2 and has the group that its homolog at least about 80% homology forms with it especially, wherein mankind VEGF-2 receptor protein has the aminoacid sequence as provided in SEQ ID NO 1 especially, as vaccine.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×